Michael Finney

Michael J.
Finney is the founder of Addition Therapeutics, Inc. Current jobs include Managing Director at Finney Capital since 2004, Director at Orion Genomics LLC since 2019, Director at Thrive Bioscience, Inc., Director at seqWell, Inc. since 2019, Director at KarnaTeq, Inc. since 2019, Director at S2 Genomics, Inc. since 2019, and Board Chair at Essen Instruments, Inc. since 2005.
Former jobs include Chief Executive Officer at Vaxart, Inc. from 2009 to 2011, Independent Chairman at Vaxart, Inc. from 2024 to 2025, Director at Banyan Energy, Inc. from 2013 to 2016, Director at Innerscope Research, Inc. from 2009 to 2016, Director at PharmaSecure, Inc. in 2009, Director at Nanotech Biomachines, Inc., Director at Essen Instruments, Inc., CSO and Board Director at MJ Research, Inc. from 1985 to 2004, Director at Mission Motor Co. from 2009 to 2010, and Director at Driver Bioengineering, Inc. from 2017 to 2019.
Education includes an undergraduate degree from Harvard University conferred in 1980 and a doctorate from the Massachusetts Institute of Technology conferred in 1987.